Number of Shares
41,550.00
Current Holdings Value*
$1.68 Mil
% of Portfolio
0.57%
Total Estimate Gain
$389,739.00
% of Total Estimate Gain
22.13%

Loomis Sayles Small Cap Growth Portfolio's Akero Therapeutics Inc Holding Summary

As of 2025-03-31, Brighthouse Funds Trust II held 41,550.00 shares of Akero Therapeutics Inc(AKRO), totaling $1.68 Mil. This investment constitutes 0.57% of their stock portfolio, and Brighthouse Funds Trust II now holds 0.05% of the outstanding Akero Therapeutics Inc(AKRO) stock.

The initial trade took place in 2025Q1. And since then Loomis Sayles Small Cap Growth Portfolio has made 1 purchases of AKRO, at an average price of $42.39, for a total of 41,550.00 shares. Based on historical transaction data and AKRO's current price of $51.77, Loomis Sayles Small Cap Growth Portfolio's estimated gain on his AKRO holdings is $389,739.00, reflecting a 22.13% gain to date.

Loomis Sayles Small Cap Growth Portfolio AKRO ($51.77) Holding Chart

Loomis Sayles Small Cap Growth Portfolio AKRO ($51.77) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1